New York City-based Mount Sinai Health System’s pharmacy leaders are no longer debating whether to adopt AI. The question now is where to focus — and how to move from exploration to execution without introducing friction into daily workflows. “We…
Pharmacy
Louisiana Attorney General Liz Murrill has reached a $45 million settlement with CVS Health and its pharmacy benefit manager subsidiary, resolving three lawsuits over alleged regulatory and competitive misconduct. The lawsuits concerned allegations related to consumer communications about pending legislation,…
The FDA has released draft guidance outlining an approval pathway for individualized therapies aimed at ultra-rare diseases, building on a framework first outlined by agency leaders in November. The proposed pathway, dubbed the “Plausible Mechanism Framework,” would allow sponsors to…
Marshall University School of Pharmacy in Huntington, W.Va., became the first pharmacy school in the U.S. to record a 100% pass rate on the 2025 West Virginia pharmacy law licensure exam. The exam, officially known as the Multistate Pharmacy Jurisprudence…
Hospital groups are asking HHS to give stakeholders more time to weigh in on a potential overhaul of the 340B drug pricing program, warning that the current 30-day comment period isn’t sufficient to evaluate how a shift from upfront discounts…
Advertisement
The Administration for Strategic Preparedness and Response, an agency within HHS, is investing $15 million to scale domestic production of shikimic acid, a key starting material for the antiviral drug Tamiflu (oseltamivir). The investment is intended to address the nation’s…
Detroit-based Henry Ford Health has administered Michigan’s first commercial infusion of Roctavian, a gene therapy for hemophilia A. The one-time infusion was given Jan. 15 to a man with severe hemophilia A at the infusion and chemotherapy treatment center at…
Two Connecticut cities filed federal lawsuits against Cigna, CVS Health and UnitedHealth Group — targeting their pharmacy benefit managers — over an alleged “insulin pricing scheme,” according to January filings in the U.S. District Court for the state. Along with…
The FDA plans to drop its long-standing requirement that drugmakers conduct two rigorous studies to secure approval for new drugs and is also pushing to expand over-the-counter access to medications. Going forward, the FDA’s “default position” will be to require…
BCBS Michigan saved $67 million and $80 million in 2024 and 2025, respectively, through biosimilar use, the insurer reported Feb. 17. The company began moving members from Humira and Stelara to alternatives like Simlandi and Yesintek in 2025. Currently, 99% of members…